These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30602968)

  • 1. Problems encountered in conventional HIV 1/2 Algorithms: lack of necessity for immunoblot assays to confirm repeated ELISA reactive results.
    Yuksel P; Saribas S; Kuskucu M; Mutcali SI; Kosan E; Habip Z; Demirci M; Kara ES; Birinci I; Caliskan R; Dinc HO; Midilli K; Ziver T; Kocazeybek B
    Afr Health Sci; 2018 Jun; 18(2):407-416. PubMed ID: 30602968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience of the National HIV-AIDS Reference Center of Turkey, in the Transition to the New HIV Diagnostic Algorithm; Comparative Analysis of Line-Immunoassay Test and Bio-Rad Geenius™ HIV-1/2 Antibody Confirmatory Assay].
    Demir T; Yıldıran D; Kılıç S
    Mikrobiyol Bul; 2021 Jan; 55(1):17-29. PubMed ID: 33590978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays.
    Tuaillon E; Sanosyan A; Pisoni A; Liscouët J; Makinson A; Perre PV
    J Clin Virol; 2017 Oct; 95():47-51. PubMed ID: 28843384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
    Montesinos I; Eykmans J; Delforge ML
    J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two HIV antibody confirmatory assays: Geenius™ HIV1/2 Confirmatory Assay and the recomLine HIV-1 & HIV-2 IgG Line Immunoassay.
    Friedrichs I; Buus C; Berger A; Keppler OT; Rabenau HF
    J Virol Methods; 2015 Nov; 224():91-4. PubMed ID: 26315319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
    Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
    PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
    Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
    J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of the Multispot HIV-1/HIV-2 rapid test to correctly differentiate HIV-2 from HIV-1 infection in screening algorithms using third and fourth generation assays and to identify cross reactivity with the HIV-1 Western Blot.
    Ramos EM; Harb S; Dragavon J; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e104-7. PubMed ID: 24342468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of Two Anti-HIV Confirmatory Assays: Recombinant HIV 1/2 Line Immunoassay and Geenius HIV 1/2 Confirmatory Test].
    Zeytinoğlu A; Kayın M; Altuğlu İ; Gökengin D; Sertöz R
    Mikrobiyol Bul; 2020 Oct; 54(4):613-618. PubMed ID: 33107290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a synthetic peptide of HIV-2 glycoprotein 36 in antigen mixtures for the immunodiagnosis of HIV types 1 and 2].
    Ramos Martínez G; Valdespino-Díaz MA; Hernández Marín M; Valle Carvajal E; Selles León ME; Pozo Peña L
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):663-5. PubMed ID: 25639906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of HIV-1/2 antibody confirmatory assay: Geenius™ versus INNO-LIA™].
    Aguinaga A; Navascués A; Polo I; Ezpeleta C
    Rev Esp Quimioter; 2017 Feb; 30(1):40-44. PubMed ID: 28010056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Bio-Rad HIV-1/2 Confirmatory Assay in HIV-1, HIV-2 and HIV-1/2 dually reactive patients - comparison with INNO-LIA and immunocomb discriminatory assays.
    Lindman J; Hønge BL; Kjerulff B; Medina C; da Silva ZJ; Erikstrup C; Norrgren H; Månsson F
    J Virol Methods; 2019 Jun; 268():42-47. PubMed ID: 30871983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV‑2 antibody detection after indeterminate or negative HIV‑1 Western blot in Cuba, 2005-2008.
    Díaz DF; Ortiz E; Martín D; Nibot C; Rizo A; Silva E
    MEDICC Rev; 2012 Jan; 14(1):25-9. PubMed ID: 22334109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area.
    Andersson S; da Silva Z; Norrgren H; Dias F; Biberfeld G
    AIDS; 1997 Dec; 11(15):1815-22. PubMed ID: 9412699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use in Mozambique of WHO diagnostic strategies in HIV infection].
    Louis FJ; Perret JL; Morillon M; Pina JJ; Lesens O; de Vaucouleurs AB; Martet G
    Sante; 1999; 9(2):111-4. PubMed ID: 10377498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
    Chacón L; Mateos ML; Holguín Á
    J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China.
    Liu MQ; Zhu ZR; Kong WH; Tang L; Peng JS; Wang X; Xu J; Schilling RF; Cai T; Zhou W
    J Med Virol; 2016 Aug; 88(8):1462-6. PubMed ID: 26856240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.